← Open Payments lookup

AMY YAGER: Open Payments

NPI 1396996948 · OMAHA, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,754 in 65 payments from 11 companies in 2025. Trend: 2023 $5,016 · 2024 $3,471 · 2025 $1,754

Food & beverage: $1,754
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)25$456
Alkermes, Inc.11$447
ABBVIE INC.6$183
Axsome Therapeutics, Inc.3$154
Otsuka America Pharmaceutical, Inc.2$143
Vanda Pharmaceuticals Inc.4$105
Supernus Pharmaceuticals, Inc.5$88
Teva Pharmaceuticals USA, Inc.4$80
Takeda Pharmaceuticals U.S.A., Inc.3$53
Janssen Pharmaceuticals, Inc1$28

Products named: CAPLYTA, ARISTADA, VRAYLAR, Auvelity, VIVITROL, ABILIFY MAINTENA, LYBALVI, HETLIOZ.

Industry payments across NE — which companies pay providers there.